Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gap decrease » gain decreased (Expand Search), mean decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gap decrease » gain decreased (Expand Search), mean decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
661
Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019).
Published 2025Subjects: -
662
-
663
Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.
Published 2025Subjects: -
664
General information of patient who diagnosis insomnia disorder (N = 518,119).
Published 2025Subjects: -
665
Detailed treatment status of people who received non- pharmacological treatment at first diagnosis.
Published 2025Subjects: -
666
-
667
-
668
-
669
-
670
Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells).
Published 2024Subjects: -
671
-
672
-
673
-
674
Control (Ctrl) GECs are more susceptible to injury compared to iPLA<sub>2</sub>γ KO GECs.
Published 2024Subjects: -
675
-
676
KO of iPLA<sub>2</sub>γ attenuates development of albuminuria in STZ-induced diabetic nephropathy.
Published 2024Subjects: -
677
Bar graphs showing the means and 95% CI of each retinal layer thickness at each visit.
Published 2025Subjects: -
678
-
679
Rates of change in each retinal layer thickness, calculated using linear mixed models.
Published 2025Subjects: -
680